Drug development is a long and complicated process. Traditional drugs need to be screened through a large number of repeated experiments by laboratory personnel among tens of thousands of drug compounds, and further obtain candidate drugs from lead compounds. The screening process is long and consumes a lot of manpower and material resources. The screening results are affected by many factors, such as the accuracy of manual operation, the impact of the experimental environment, the reproducibility of experimental results, etc. NAYO pharmaceutical R&D Automation Solution relies on an automated and intelligent platform to help automate, efficiently and digitalize drug development.